Summary of Classification and Labelling
Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation)
General Information
ATP Inserted / Updated: CLP00 ![]() CLP Classification (Table 3)
|
Seveso III Data
Disclaimer: Please note that some of the substances covered by the Seveso Directive can belong to more than one Seveso categories. It will be up to the users to decide whether their substance or mixture fall in one or in more of these classification categories depending on the tonnage bands and the concentrations.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.
Seveso Data | |
---|---|
Seveso Substance | Seveso Categories |
Sì |
P8
|
Notified classification and labelling
General Information
EC / List no.
![]() |
Name |
CAS Number
![]() |
---|---|---|
231-512-4 | Perchloric acid | 7601-90-3 |
Notified classification and labelling according to CLP criteria
Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
---|---|---|---|---|---|---|---|---|---|---|---|
Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS05 Dgr |
Skin Irrit. 2; : 1 % ≤ C < 10 % Skin Corr. 1A; : C ≥ 50 % Ox. Liq. 1; : C > 50 % Ox. Liq. 2; : C ≤ 50 % Eye Irrit. 2; : 1 % ≤ C < 10 % Skin Corr. 1B; : 10 % ≤ C < 50 % |
State/Form
|
13 | ![]() |
View details | |||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS07 GHS08 GHS05 Dgr |
Ox. Liq. 2; : C ≤ 50 % Skin Irrit. 2; : 1 % ≤ C < 10 % Ox. Liq. 1; : C > 50 % Skin Corr. 1A; : C ≥ 50 % Skin Corr. 1B; : 10 % ≤ C < 50 % Eye Irrit. 2; : 1 % ≤ C < 10 % |
State/Form
|
12 | ![]() |
View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Acute Tox. 4 | H302 | H302 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
STOT RE 2 | H373 (Thyroid) | H373 (Thyroid) | |||||||||
STOT RE 2 | H373 (other:Thyroid) | H373 (Thyroid) | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS08 GHS07 GHS05 Dgr |
State/Form
|
1 | ![]() |
View details | ||||
Met. Corr. 1 | H290 | H290 | |||||||||
Acute Tox. 4 | H302 | H302 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
STOT RE 2 | H373 (other:Thyroid) | H373 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS05 Dgr |
Ox. Liq. 1; : C > 50 % Skin Corr. 1B; : 10 % ≤ C < 50 % Skin Irrit. 2; : 1 % ≤ C < 10 % Ox. Liq. 2; : C ≤ 50 % Skin Corr. 1A; : C ≥ 50 % Eye Irrit. 2; : 1 % ≤ C < 10 % |
Note B
|
State/Form
|
136 | View details | |||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS07 GHS05 Dgr |
Skin Corr. 1A; : C ≥ 50 % Ox. Liq. 2; : C ≤ 50 % Eye Irrit. 2; : 1 % ≤ C < 10 % Skin Corr. 1B; : 10 % ≤ C < 50 % Skin Irrit. 2; : 1 % ≤ C < 10 % Ox. Liq. 1; : C > 50 % |
Note B
|
State/Form
|
14 | View details | |||
Acute Tox. 4 | H302 | H302 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS07 GHS08 GHS05 Dgr |
6 | View details | ||||||
Acute Tox. 4 | H302 | H302 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | H318 | |||||||||
STOT SE 1 | H370 (Respiratory tra...) (inhalation) | H370 (i) | |||||||||
STOT SE 1 | H370 (other:Respirato...) (inhalation) | H370 (i) | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS05 Dgr |
Eye Irrit. 2; : C ≥ 1 % Skin Irrit. 2; : C ≥ 1 % Skin Corr. 1B; : C ≥ 10 % Ox. Liq. 1; : C ≥ 50.0001 % Skin Corr. 1A; : C ≥ 50 % Ox. Liq. 2; : C ≥ 50 % |
Note B
|
State/Form
|
2 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS05 Dgr |
State/Form
|
1 | View details | |||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS05 Dgr |
Ox. Liq. 1; : C > 50 % Ox. Liq. 2; : C ≤ 50 % Skin Corr. 1B; : 10 % ≤ C < 50 % Eye Irrit. 2; : 1 % ≤ C < 10 % Skin Irrit. 2; : 1 % ≤ C < 10 % Skin Corr. 1A; : C ≥ 50 % |
Note B
|
State/Form
|
1 | View details | |||
H290 | |||||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
H221 |
GHS03 GHS05 Dgr |
State/Form
|
1 | View details | |||||||
Ox. Liq. 1 | H271 | ||||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS05 Dgr |
Ox. Liq. 2; : C ≤ 50 % Skin Irrit. 2; : 1 % ≤ C ≤ 10 % Skin Corr. 1A; : C > 50 % Eye Irrit. 2; : 1 % ≤ C ≤ 10 % Ox. Liq. 1; : C > 50 % Skin Corr. 1B; : 10 % ≤ C ≤ 50 % |
Note B
|
State/Form
|
1 | View details | |||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS05 Dgr |
Skin Corr. 1A; : C ≥ 50 % Skin Irrit. 2; : 1 % ≤ C < 10 % Ox. Liq. 2; : C ≤ 50 % Eye Irrit. 2; : 1 % ≤ C < 10 % Ox. Liq. 1; : C > 50 % Skin Corr. 1B; : 10 % ≤ C < 50 % |
Note B
|
State/Form
|
1 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS05 Dgr |
Skin Corr. 1B; : 10 % ≤ C < 50 % Ox. Liq. 1; : C > 50 % Skin Corr. 1A; : C ≥ 50 % Skin Irrit. 2; : 1 % ≤ C < 10 % Ox. Liq. 2; : C ≤ 50 % |
State/Form
|
1 | View details | ||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS08 GHS05 Dgr |
Ox. Liq. 1; : C > 50 % Eye Irrit. 2; : 1 % ≤ C < 10 % Skin Irrit. 2; : 1 % ≤ C < 10 % Ox. Liq. 2; : C ≤ 50 % Skin Corr. 1A; : C ≥ 50 % Skin Corr. 1B; : 10 % ≤ C < 50 % |
1 | View details | |||||
Skin Corr. 1A | H314 | H314 | |||||||||
STOT RE 2 | H373 (Thyroids) (oral) | H373 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS07 GHS08 GHS05 Dgr |
Skin Corr. 1B; : 10 % ≤ C < 50 % Ox. Liq. 2; : C ≤ 50 % Skin Corr. 1A; : C ≥ 50 % Eye Irrit. 2; : 1 % ≤ C < 10 % Skin Irrit. 2; : 1 % ≤ C < 10 % Ox. Liq. 1; : C > 50 % |
Note B
|
State/Form
|
1 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Acute Tox. 4 | H302 | H302 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
STOT RE 2 | H373 (other:thyroid) (dermal,inhalati...) | H373 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS07 GHS08 GHS05 Dgr |
Eye Irrit. 2; : 1 % ≤ C < 10 % Skin Corr. 1B; : 10 % ≤ C < 50 % Skin Corr. 1A; : C ≥ 50 % Skin Irrit. 2; : 1 % ≤ C < 10 % Ox. Liq. 1; : C > 50 % Ox. Liq. 2; : C ≤ 50 % |
Note B
|
State/Form
|
1 | View details | |||
Met. Corr. 1 | H290 | H290 | |||||||||
Acute Tox. 4 | H302 | H302 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 | ||||||||||
STOT RE 2 | H373 (other:tyroid) (oral) | H373 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS05 Dgr |
Ox. Liq. 1; : C > 50 % Skin Irrit. 2; : 1 % ≤ C < 10 % Ox. Liq. 2; : C ≤ 50 % Eye Irrit. 2; : 1 % ≤ C < 10 % Skin Corr. 1A; : C ≥ 50 % Skin Corr. 1B; : 10 % ≤ C < 50 % |
Note B
|
![]() |
State/Form
|
1 | View details | ||
Met. Corr. 1 | H290 | H290 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS08 GHS07 GHS05 Dgr |
State/Form
|
1 | View details | |||||
Met. Corr. 1 | H290 | H290 | |||||||||
Acute Tox. 4 | H302 | H302 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
STOT RE 2 | H373 (dermal,inhalati...) | H373 | |||||||||
Ox. Liq. 1 | H271 | H271 |
GHS03 GHS07 GHS05 Dgr |
State/Form
|
1 | View details | |||||
Met. Corr. 1 | H290 | H290 | |||||||||
Acute Tox. 4 | H302 | H302 | |||||||||
Skin Corr. 1A | H314 | H314 | |||||||||
Eye Dam. 1 | H318 |
Number of Aggregated Notifications: 19